Cite
HARVARD Citation
Lew, E. et al. (n.d.). Immuno-oncologic efficacy of RXDX-106, a selective, TAM family small molecule kinase inhibitor. European journal of cancer. pp. S31-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lew, E. et al. (n.d.). Immuno-oncologic efficacy of RXDX-106, a selective, TAM family small molecule kinase inhibitor. European journal of cancer. pp. S31-. [Online].